This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Franck Pelissier: Innovator in Cancer Treatment
Introduction
Franck Pelissier is a notable inventor based in GIF S/Yvette, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. His work focuses on addressing diseases related to excessive angiogenesis, which is crucial in cancer progression.
Latest Patents
Franck Pelissier holds a patent for the use of a novel 3-aryl-4-catechol-pyrrole-N-propanol compound and its derivatives to treat cancer and diseases associated with excessive angiogenesis. The patent describes a compound with a general formula that includes an aryl group, which can be substituted by various functional groups. The invention also details methods for preparing the compound, pharmaceutical compositions containing it, and its application as a drug or prodrug in cancer treatment.
Career Highlights
Pelissier is affiliated with the Centre National de la Recherche Scientifique, where he conducts his research. His work has been instrumental in advancing the understanding of how specific compounds can be utilized in medical treatments. His dedication to innovation in the pharmaceutical field has positioned him as a key figure in cancer research.
Collaborations
Throughout his career, Franck Pelissier has collaborated with esteemed colleagues such as Pascal Collin and Bernard Delpech. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.
Conclusion
Franck Pelissier's contributions to cancer treatment through his innovative patent and research at the Centre National de la Recherche Scientifique highlight his commitment to advancing medical science. His work continues to inspire future innovations in the field.